Evidence map›Paper›PMID 40702276›Full record

ArticleInterdisciplinary sciences, computational life sciences2026

A Semi-supervised Reinforcement Learning Framework Incorporating the Multi-scale IncepMambaNet Network for Glaucoma Progression Prediction.

Xue Pan, Ze Xiong, Dehui Qiu, Liguo Deng, Boxuan Zhao, Xiaojie Cao, Xiaohua Wan, Fa Zhang

Abstract read
PubMed Publisher
In one paragraph

Article in Interdisciplinary sciences, computational life sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Xue Pan *Department of Ophthalmology, Beijing Shijitan Hospital, Beijing, 100038, China.
Ze Xiong *Information Engineering College, Capital Normal University, Beijing, 100048, China.
Dehui QiuInformation Engineering College, Capital Normal University, Beijing, 100048, China. qiudehui@cnu.edu.cn.ORCID http://orcid.org/0009-0001-5650-2021
Liguo DengInformation Engineering College, Capital Normal University, Beijing, 100048, China.
Boxuan ZhaoInformation Engineering College, Capital Normal University, Beijing, 100048, China.
Xiaojie CaoInformation Engineering College, Capital Normal University, Beijing, 100048, China.
Xiaohua WanThe Key Laboratory of Brain Health Intelligent Evaluation and Intervention, Ministry of Education (Beijing Institute of Technology), Beijing, 100081, China. wanxiaohua@bit.edu.cn.
Fa ZhangThe Key Laboratory of Brain Health Intelligent Evaluation and Intervention, Ministry of Education (Beijing Institute of Technology), Beijing, 100081, China. zhangfa@bit.edu.cn.

Funding

National Natural Science Foundation of China No. 32241027National Natural Science Foundation of China No. 61932018National Natural Science Foundation of China No. 62072441National Natural Science Foundation of China No. 62472034Natural Science Foundation of Beijing Municipality QY24308
6 · The paper itself

Abstract

Glaucoma is the leading cause of irreversible blindness worldwide. Currently, artificial intelligence (AI) technology combined with optical coherence tomography (OCT) and visual field testing is widely used for glaucoma progression prediction. However, the lack of labeled patient data and the ambiguity of structural differences in glaucoma remain major research bottlenecks. To address this, this paper proposes a glaucoma progression prediction method based on a semi-supervised reinforcement learning (SSRL) framework. In the SSRL framework, we design a key experience filtering strategy (KEFS) that prioritizes high-value training samples to enhance the model's generalization ability and optimize the quality of pseudo-labels. Additionally, an entropy regularization technique is introduced to encourage high-entropy distributions, preventing the model from prematurely converging to specific decisions and improving its ability to explore unlabeled data. To adapt the classifier and the pseudo-label generator within the SSRL framework, we innovatively propose the IncepMambaNet multi-scale network. This network integrates the visual state space (VSS) module from the VMamba model with traditional CNN structures, designing a four-branch IncepMamba module that leverages the strengths of both approaches. Experimental results demonstrate that compared to traditional supervised learning methods, our SSRL model effectively improves the performance of various state-of-the-art (SOTA) supervised classification networks. Furthermore, compared to various SOTA classification networks, IncepMambaNet achieves leading performance in three key metrics-macro-F1, F2-score, and AUC-by 0.8%, 8.8%, and 0.9%, respectively, showcasing outstanding feature capture capability and generalization performance. Ablation studies further confirm that the multi-branch structure and channel reordering operations play a crucial role in enhancing model performance.

Indexed as

Disease ProgressionGlaucomaSupervised Machine LearningAlgorithmsConvolutional Neural NetworksHumansPrediction AlgorithmsPredictive Learning ModelsReinforcement Machine LearningTomography, Optical CoherenceCNNGlaucoma progression predictionMambaReinforcement learningSemi-supervised learning

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.